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Abstract: The purpose of this paper is to overview and summarize previously published results 
of our experiments on white rats exposed to either a single intratracheal instillation or repeated 
intraperitoneal injections of silver, gold, iron oxide, copper oxide, nickel oxide, and manganese 
oxide nanoparticles (NPs) in stable water suspensions without any chemical additives. Based 
on these results and some corroborating data of other researchers we maintain that these NPs 
are much more noxious on both cellular and systemic levels as compared with their 1 μm or 
even submicron counterparts. However, within the nanometer range the dependence of systemic 
toxicity on particle size is intricate and non-unique due to complex and often contra-directional 
relationships between the intrinsic biological aggressiveness of the specific NPs, on the one 
hand, and complex mechanisms that control their biokinetics, on the other. Our data testify to the 
high activity of the pulmonary phagocytosis of NPs deposited in airways. This fact suggests that 
safe levels of exposure to airborne NPs are possible in principle. However, there are no reliable 
foundations for establishing different permissible exposure levels for particles of different size 
within the nanometric range. For workroom air, such permissible exposure levels of metallic NP 
can be proposed at this stage, even if tentatively, based on a sufficiently conservative approach 
of decreasing approximately tenfold the exposure limits officially established for respective 
micro-scale industrial aerosols. It was shown that against the background of adequately com-
posed combinations of some bioactive agents (comprising pectin, multivitamin-multimineral 
preparations, some amino acids, and omega-3 polyunsaturated fatty acid) the systemic toxicity 
and even genotoxicity of metallic NPs could be markedly attenuated. Therefore we believe that, 
along with decreasing NP-exposures, enhancing organisms’ resistance to their adverse action 
with the help of such bioprotectors can prove an efficient auxiliary tool of health risk manage-
ment in occupations connected with them. 
Keywords: nanoparticles, metals, metal oxides, toxicity
Introduction
Nanoparticles (NPs) of metals and of their oxides are of special interest in the light of 
health risks’ assessment and management because, along with engineered NPs, there 
exists usually a substantial fraction of nanoscale (“ultrafine”) particles of the same 
substances within the particle size distribution of condensation aerosols generated by 
arc-welding and metallurgical technologies. However in such aerosols chemically 
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similar micrometer particles (MPs), including submicron 
ones having dimensions 100 nm, are usually present 
as well. 
Thus, for metallic NPs more urgently than for many oth-
ers, some theoretical problems of nanotoxicology in everyday 
practice needs solving: 
1. Are NPs recognized by organisms’ main defenses worse 
than or just as well as respective MPs are? 
2. Are they much more toxic as compared with MPs on both 
cellular and systemic levels? 
3. Is there a definite dependence of defense and adverse 
responses to NPs on their dimensions within the con-
ventional nanometer range and/or on their chemical 
nature?
4. The last but not the least, is it possible to protect health of 
people dealing with either engineered or “spontaneous” 
NPs a) by establishing low but still practicable permissible 
exposure levels (PELs) and b) by enhancing organisms’ 
resistance to NPs toxicity (genotoxicity included)? 
During 2009–2014 our experimental work was focused 
on trying to find answers to these important questions.1–10
Although in the vast nanotoxicological literature of the 
last decade studies concerned with the assessment of metal 
or metal-oxide NP toxicity are not at the top of the list, such 
publications are nevertheless quite numerous. To illustrate 
this, we may refer to several works devoted to NPs of the met-
als that were the subject-matter of our own studies considered 
below: iron oxide,11–20 silver,21–45 gold,24,45–58 copper and copper 
oxide,43,59–68 nickel oxide,65,69–73 and manganese oxides.74–76 A 
comprehensive critical review of relevant publications is out 
of this paper’s scope. It should be stressed, however, that the 
prevailing majority of published researches assessed the cyto-
toxicity and genotoxicity of NPs on stable cell lines and only 
rarely on laboratory animals. No doubt, in vitro  experiments 
feature a number of well-known advantages, in particular, 
relating to analysis of primary mechanisms of toxicity. At 
the same time, any extrapolation of the results of these 
experiments to the organism level is associated with a number 
of uncertainties and assumptions. Moreover, some important 
aspects (in particular¸ toxicokinetics, dose-systemic response 
relationships, the functioning and efficiency of protective 
mechanisms) can generally be addressed only through experi-
ments on mammals’ whole organism. 
Materials and methods
Here we are giving but a brief overview of methodology 
used in our experiments which were described in detail in 
original articles.1–10
We experimented with NPs of iron oxide Fe
3
O
4 
(magne-
tite) having mean diameters 10 nm, 50 nm or 1 mcm, gold 
(4 nm or 50 nm), silver (4 nm, 49 nm or 1.1 mcm), copper 
oxide (20 nm or 340 nm), nickel oxide NiO (30 nm), and 
manganese oxide Mn
3
O
4
 (32 nm). Keeping in mind the 
above mentioned theoretical premises of our research, we 
used purposefully prepared and accurately characterized 
NPs of pure metals or their oxides suspended in deionized 
water rather than commercial nanomaterials. Only iron oxide 
magnetite NPs were synthesized chemically1–3 while in all 
other cases we used a technique of laser ablation of a 99.99% 
pure metal target in water followed by laser fragmentation for 
preventing particle aggregation. The main advantages of this 
technique are as follows: a) it provides nano-suspensions with 
a sufficiently narrow particle size distribution (examples are 
shown in Figures 1 and 2) and b) these suspensions are highly 
stable as a rule, maintaining their characteristics without 
any noticeable particle aggregation over periods sufficient 
for carrying out experiments described below. In no experi-
ment did we add any chemical stabilizer to the suspension, 
Figure 1 Images of nanoparticles in suspension obtained by scanning electron microscopy at ×150,000.
Notes: (A) Nanogold; (B) nanosilver.
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and only in experiments with magnetite and NiO NPs did 
we have to sonicate the suspensions just before instillations 
or injections. 
All experiments were carried out on outbred white female 
rats from our own breeding colony with an initial body 
weight of 150 to 220 g, with a minimum of 12 animals in 
different exposed and control groups. Rats were housed in 
conventional conditions, breathed unfiltered air, and were fed 
standard balanced food. The experiments were planned and 
implemented in accordance with the “International Guiding 
Principles for Biomedical Research Involving Animals” 
developed by the Council for International Organizations 
of Medical Sciences (1985) and approved by the Committee 
on Ethics of the Ekaterinburg Medical Research Center for 
Prophylaxis and Health Protection in Industrial Workers.
A single intratracheal (IT) instillation of 1 mL of NP 
or MP water suspension (or of the same deionized water 
without any particles to controls) served as an experimental 
model for the response of the low airways to particle deposi-
tion. It is well-known that important qualitative and quan-
titative patterns of the response of the pulmonary free cell 
population (in particular, its dependence on the cytotoxicity 
of deposited particles) observed in inhalation exposures to 
dust particles are principally the same in the case of their 
IT administration.77 At the same time, IT model provided 
cellular material for studying the phagocytizing activity of 
pulmonary macrophages and polymorphonuclear leuko-
cytes, as well as intracellular localization of NPs engulfed 
by them and ultrastructural damage caused to the cell by 
those NPs. The results thus obtained are comparable to the 
data obtained by other researchers in experiments on cell 
cultures but give a valuable addition to the latter because 
in vivo interaction between cells and particles occurs in a 
microenvironment which is not reproducible by artificial 
cell culture media.
A cell population of bronchoalveolar lavage fluid (BALF) 
obtained 24 hours after IT instillation to rats of NP or MP 
suspensions was studied with optical microscopy, transmis-
sion electron microscopy (TEM), and semi-contact atomic 
force microscopy (sc-AFM).
Subchronic toxicity was modeled by means of repeated 
intraperitoneal (IP) injections of the same particles during 
5–7 weeks. Using IP injections for modeling systemic intoxi-
cation, which in real conditions can be induced by long-term 
inhalation exposure of workers needs some justification. It 
is well-known that “NPs deposit with high efficiency in the 
entire respiratory tract, from the head airways to the alveoli, 
due to diffusion”.78 For instance, the widely used Human 
Respiratory Tract Model of the International Commission 
of Radiological Protection79,80 predicts 100% total deposition 
of 0.001 μm (ie, 1 nm) and ~90% for 0.01 μm (ie, 10 nm) 
particles for a normal adult mouth breathing male human 
subject. However there are many anatomical, functional, and 
aerodynamic differences between humans and rodents which 
make one assume interspecies distinctions in regional particle 
deposition and thus in the kinetics of their elimination from 
the airways to the gastrointestinal tract and/or absorption. 
No wonder that the authors of a comprehensive review of 
nanotoxicological assessment techniques81 maintain that:
Rodents, the commonly used species for toxicology testing, 
are obligatory nose breathers and, therefore, not representa-
tive models for human respiratory inhalation exposure. 
In other words, NP inhalation by laboratory rodents is 
not as ideal a model of real human exposure as it is often 
deemed to be.
The IP model permits one to circumvent these interspe-
cies differences of inhaled NP deposition and is adequate 
enough when one wants to look into body distribution and 
elimination of NPs, and for organisms’ reactions to NPs after 
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Figure 2 Nanoparticle (NP) size distribution function.
Notes: The results of statistical processing of 800 images of gold NPs (A) and 650 images of silver NPs (B) obtained by scanning electron microscopy.
Abbreviations: d, diameters of nanoparticles; N/N, number of nanoparticles.
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they have penetrated into the blood from a primary deposit. 
Like any model (always a necessary simplification of a 
complicated system deliberately omitting some sub-systems 
and some material or informational flows and feedbacks), 
it has both drawbacks and virtues. Among the latter, one 
should take into consideration that dosing by injection is 
much more accurate and reliable as compared with the more 
“natural” experimental methods. This reason is crucial for 
experiments of comparative design like ours. IP modeling 
of subchronic intoxications is well-known and recognized 
in general experimental toxicology. Moreover, it was used 
just in experimental nano-toxicological studies also by other 
researchers.82,83
In our experiments, systemic toxic effects of particles 
under comparison were characterized by a lot of biochemical 
and functional tests, typically comprising: 
•	 weighing of the body and inner organs; 
•	 estimation of the central nervous system ability for the 
temporal summation of sub-threshold impulses (a vari-
ant of withdrawal reflex and its facilitation by repeated 
electrical stimulations in intact, conscious rat);84 
•	 recording of the number of head-dips into the holes of a 
hole-board, which is frequently used for studying behav-
ioral effects of toxicants and drugs;85,86 
•	 24 hours collection of urine for measuring its density, 
urine output, coproporphyrin, delta-aminolevulinic acid 
(δ-ALA), and creatinine contents; 
•	 sampling of capillary blood from a notch on the tail for 
examining the hemogram, hemoglobin content, and for 
cytochemical determination of SDH activity in lymphocytes 
(by the reduction of nitrotetrazolium violet to formasan);
•	 collecting blood by exsanguination from rats killed by 
decapitation for measuring concentrations of reduced 
glutathione, total serum protein, albumin, globulin, 
bilirubin, ceruloplasmin, malondialdehyde, ALP, ALT, 
AST, CAT, GGT, SH-groups, and creatinine. 
The metal content of the liver, spleen, kidneys, and brain 
was determined with the help of atomic emission spec-
trometry and, for iron oxide particles, also by the electron 
paramagnetic resonance method. 
Thin sections of different organs were prepared for his-
tological examination by hematoxylin and eosin stain and, 
where necessary, periodic acid Schiff, Nissl and Perl’s stains. 
We used a planimetric ocular grid for morphometry of spleen 
and liver and an image recognition programmed system for 
that of kidneys and brain.
In the subchronic experiments with NPs and MPs of 
Ag, Au, and CuO the genomic DNA fragmentation was 
assessed in cells of several tissues using the random ampli-
fied polymorphic DNA test.
Both systemic and genotoxicity of nAg and of nCuO were 
assessed also against the background of oral administration 
of bio-protective complexes (BPC) comprising pectin, 
multivitamin–multimineral preparations, some amino 
acids, and omega-3 polyunsaturated fatty acid.7,8 Pre-
medication with a similar BPC (without pectin) was 
administered to rats instilled afterward intratracheally with 
NiO+Mn
3
O
4 
NPs.10 
Main results and discussion 
We propose to summarize and discuss our results in light of 
the questions suggested in the Introduction.
Are NPs recognized and dealt with 
by the organism worse than, or just as 
well as or even better than respective 
microparticles are? 
Practical implications of this seemingly theoretical question 
hardly needs explanation. Indeed, if physiological defenses 
against NPs are of a low effectiveness one should assume 
that non-harmful exposures to NPs would be hardly possible, 
in principle. In other words, no safe exposure levels for NPs 
in the environment should be established. 
This problem is not contrived by us. In the beginning 
of the “nanotoxicological era”, it was maintained by some 
authors (for instance Donaldson et al and Oberdörster 
et al)87,88 that the physiological protective mechanisms 
enabling animals and humans to exist in an atmosphere 
unavoidably polluted with suspended particles of a wide 
range of sizes and chemical compositions have, for whatever 
reasons, little effectiveness in relation to NPs. It was thought, 
specifically, that NPs deposited in the pulmonary region are 
not efficiently phagocytized by alveolar macrophages (AM) 
due either to their inability to recognize the smallest par-
ticles or to the failure of the latter to generate a chemotactic 
signal at the site of their deposition. For instance, 10 years 
ago a highly reputable group of experts88 maintained that 
“very small particles [...] may not be detected by the normal 
phagocytic defenses”. Even as recently as in 2012 the author 
of a comprehensive review89 did not present this problem 
as solved: 
Macrophages engulf microbes and apoptotic debris, but 
the question is: are NPs recognized by phagocytes or do 
such particles fly under the radar and escape immune 
recognition? 
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We started off our own research into this field1,2 with 
some criticism of the research data seemingly corroborat-
ing those views and with skepticism based on evolutionary 
considerations. We stressed that terrestrial vertebrates have 
had to inhale ultrafine nanoscale particles (such as volcanic 
ash, airborne particles of dispersed seawater, forest fire 
smoke, sulfates generated in the atmosphere as a result of 
sulfur dioxide oxidation) for as long as they have inhaled fine 
microparticles. We reminded that both main mechanisms of 
pulmonary clearance (engulfing of particles by phagocytes 
and mucociliary transport) had been present already in 
amphibians,90 that is even before the morphological structur-
ing of the lungs was complete. We maintained that it would 
be difficult to understand why these ancient defenses, highly 
efficient in relation to MPs, should have been selected and 
fixed by the evolution had they been ineffective in relation 
to NPs against which defense is even more necessary since 
they are presumably more noxious (see below). 
From the very first experiment, however, our data sug-
gested that organism are not defenseless when confronted 
with metallic NPs’ exposures. In particular, we have found 
that just the pulmonary phagocytosis response to deposition 
of NPs is quite potent. In several experiments it was found 
that, given equal mass doses and identical metal composition, 
NPs induced intensive recruitment of phagocytes increasing 
cell count in the BALF to a greater degree than MPs did. One 
example illustrating this is given in Table 1. Moreover, this 
recruitment and especially an increase in neutrophil leuko-
cytes (NL) to AM ratio in the BALF cell count is the more 
pronounced, the smaller is the particle within the nanoscale 
range as illustrated by Figure 3.
Such NLs’ recruitment toward the lower airways in 
response to the deposition of particles is quite often described 
as “inflammation” and, thus, as a pathological phenomenon 
rather than a pulmonary defense mechanism. This concept is 
common to nanotoxicological studies as well.73,91–95 We main-
tain, however, that it can be misleading. Beyond any doubt, 
enhanced recruitment of NLs onto the free surface of lower 
airways is typical of acute and, to a lesser degree, chronic 
inflammatory processes induced by microbial or chemical 
agents. However, a certain number of NLs is always present in 
the BALF of healthy animals, at least when they are constantly 
inhaling unfiltered air. They are hardly always living with 
chronic inflammation of the respiratory system. Meantime, it is 
long ago that we96–100 found fairly strong reasons for consider-
ing the NL recruitment response to be an important mechanism 
of partial compensation for the damage caused by cytotoxic 
micrometric particles to AMs, the main effector of the pulmo-
nary clearance. A mathematical multi-compartmental model 
of pulmonary region clearance which comprised just this 
compensatory mechanism simulated very well the pulmonary 
retention of dusts of varying degrees of cytotoxicity (quartzite 
rock, titanium dioxide, standard quartz DQ12) under long-term 
inhalation exposure as well as a decrease in this retention under 
the effect of such potent protectors of the macrophage against 
particle cytotoxicity as glutamate.
In the same way, data obtained in our experiments with 
metallic NPs demonstrate that in this case too the enhanced 
NL recruitment, be it a manifestation of the inflammation 
or a normal physiological pulmonary particle clearance 
mechanism, takes an important part in this cleaning process. 
It should be stressed that both types of recruited phagocytes 
(that is not only AMs but NLs as well) engulf NPs much 
more avidly compared with MPs of the same metal, and 
the smaller the diameter of particles, the more active their 
phagocytosis by these cells. We illustrate these relationships 
with an example of magnetite particles (Figure 4). 
sc-AFM reveals multiple “pits” on the surfaces of both 
AMs and NLs, and the greater the particles, the greater the 
dimensions of these pits (examples are shown in Figures 5 
and 6). At the same time, the smaller the particle, the higher 
the surface concentration of these pits (Figure 7). We con-
sider them to be not mere “footprints” of particles passively 
penetrating into cells through the cell membrane and leaving 
a hole but a fixed moment of its invagination at the first stage 
of active endocytosis. Indeed, although the mean diameter 
Table 1 Number of cells in the bronchoalveolar lavage fluid (BALF) 24 hours after the intratracheal instillation of silver nano- or 
microparticles to rats at a dose of 0.2 mg per rat (x±se)
Substance  
administered 
Number of cells ×106 NL/AM
Total Neutrophil  
leukocytes (NL)
Alveolar  
macrophages (AM)
Nanosilver (49 nm) 4.25±0.77° 2.99±0.71*,° 1.16±0.14 2.47±0.33*,°
Microsilver (1.1 μm) 1.99±0.25 0.73±0.15* 1.24±0.19 0.66±0.13*
water (controls) 1.41±0.33 0.13±0.04 0.89±0.18 0.14±0.023
Notes: Statistically significant difference *from control group; °from microsilver group (P0.05 by Student’s t-test).
Abbreviation: se, standard error.
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of these pits correlates with that of IT instilled NPs, the 
former is not equal to but usually greater than the latter. For 
instance, under exposure to 49 nm silver particles and 50 nm 
gold particles the average diameter of pits was 75.2±0.3 nm 
and 77.6±1.5 nm, respectively.7
The TEM images (Figure 8) also testify to the physiologi-
cal endocytosis of NPs as opposed to their direct penetra-
tion through cell membrane by diffusion, which, above any 
doubts, is also possible.4–6
When NPs are of given dimensions, the pulmonary 
phagocytosis response strongly depends on their chemical 
nature. For instance, as can be seen from Table 2, the total 
cell, NL and AM counts, and the macrophage count of the 
BALF increased under the impact of silver NPs more than it 
did under the impact of virtually equidimensional gold NPs. 
A similar dependence of NL recruitment on the chemical 
nature of NPs was shown in a comparative experiment with 
nano-suspensions of NiO and Mn
3
O
4
.10
Judging by the sc-AFM images, nanosilver was engulfed 
by phagocytic cells twice more avidly than nanogold since 
the average number of surface “pits” per square micrometer 
was 18.0 and 9.0, respectively.7 Under TEM it was evident 
that intracellular distribution of the internalized silver and 
gold NPs was also different, the most significant being a 
more pronounced affinity of nAg for mitochondria and a 
lesser ability to penetrate into cell nuclei as compared with 
nAu (Figures 9 and 10).7
In another experiment we compared responses to 
IT instillation of CuO NPs (20 nm) and submicron par-
ticles (340 nm) and again found that NPs evoked more 
significant recruitment of NLs than even these fine MPs did 
(9.41±2.01×106 and 3.64±0.90×106 respectively, the control 
value being 0.05±0.01×106). The respective NL/AM ratio 
6.23±0.62
7
6
5
4
3
2
1
0
4.42±0.57
0.15±0.03
Distilled water 10 nm 50 nm 1 µm
Particle size
N
L/
A
M
 ra
tio
1.32±0.27
 
Figure 3 The ratio of the number of neutrophil leukocytes (NL) to the number of 
alveolar macrophages (AM) in the bronchoalveolar lavage fluid of rats 24 hours after 
the instillation of magnetite particles of different sizes at a dose of 2 mg in 1 mL of 
distilled water (x±SX).
0–20 particles in a cell
>20 particles in a cell
10 nm
9.4%
90.6% 80.9%
19.1%
36.0%
64.0%
42.7%
27.5%
57.3%
72.5% 97.7%
2.3%
Neutrophil leukocytes 
Alveolar macrophages
50 nm 1 µm
Figure 4 Percentage of phagocytic cells with different levels of particle burden in the bronchoalveolar lavage fluid of rats 24 hours after the intratracheal instillation of Fe3O4 
particles having different diameters.
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Figure 5 Alveolar macrophage surface topography measured by semi-contact atomic force microscopy.
Notes: (A) Control; (B) after instillation of 10 nm magnetite; (C) after instillation of 50 nm magnetite; (D) after instillation of 1 μm magnetite particles.
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Figure 6 Alveolar macrophage surface topography measured by semi-contact atomic force microscopy.
Notes: (A) Controls; (B) after instillation of 340 nm copper oxide; (C) after instillation of 20 nm copper oxide particles.
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values were 4.76±1.39, 1.39±0.16, and 0.06±0.01. sc-AFM 
again revealed pits on the cell surface (Figure 6) with average 
diameters 25±1 nm under exposure to NPs and 290±14 nm 
under exposure to MPs, the average surface density of these 
pits being 32.6 and 1.9 per μm2, respectively. A hypothetical 
explanation of positive rank correlations between NL/AM 
ratio and phagocytosis activity as judged by sc-AFM will be 
discussed in the next section.
To sum up the data discussed in this sub-section, it seems 
evident that:
a) the pulmonary phagocytosis response to metallic NPs’ 
deposition (namely, phagocytes recruitment toward the 
free surface of lower airways and phagocytic activity of 
these cells) is more pronounced than to the deposition of 
respective MPs, 
b) this response depends on both NP dimensions and their 
chemical characteristics. 
Most importantly, we found that pulmonary tissue was 
indeed liberated from deposited NPs quicker than from their 
micrometric counterparts, the smaller the NPs, the quicker 
the process.1,3 We believe that this is due not only to quicker 
dissolution but also to more active phagocytosis of the small-
est NPs. However, both physicochemical and physiological 
mechanisms of NPs pulmonary clearance, while attenuating 
the harmful impact of NPs on lungs, serve as prerequisites 
for the toxic action of NPs on other organs either through 
the gastrointestinal tract (whereto they are translocated with 
the normal mucociliary transport) or directly through blood 
(as a result of their dissolution/absorption or of penetration/
diffusion). Thus we should discuss the further two crucial 
questions posed in the Introduction.
Are metallic NPs really much more toxic 
as compared with microparticles of the 
same chemical nature on both cellular 
and systemic level? If they are, is there 
a definite dependence of organisms’ 
adverse responses to NP exposure on 
their dimensions within the conventional 
nanometer range and/or on their 
chemical nature?
The paradigm of a considerably higher biological aggressive-
ness of NPs as compared with particles of the same substance 
in the micrometric range first emerged as a theoretically 
sound perception.87,88,101 Very soon some experimental facts 
corroborating this perception were obtained by different 
researchers, but this corroboration was during a period neither 
unanimous nor absolutely reliable due to some drawbacks 
and lack of comparability between different experimental 
designs. Thus, even as recently as 5 years ago very repu-
table authors would justifiably state in the oldest specialized 
nanotoxicological journal that “this common perception of 
greater NP toxicity is based on a limited number of studies”,95 
and still less was known about the comparative toxicity of 
chemically identical particles having different sizes within 
the conventional nanometric range.
However, quickly the situation has changed substantially. 
Today’s body of facts allows one to say without qualification 
that, given identical exposure pathways and similar chemis-
try, the toxic effects of metal and metal oxide NPs are much 
higher than those of their micrometer counterparts, even of 
minimal (including submicron) sizes of the latter, while for 
a given size the toxicity of NPs depends on their chemical 
nature and related properties, including solubility. Along 
with the latter property, quite often causing “the Trojan horse 
effect” (intracellular release of toxic metal ions by engulfed 
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Figure 7 Average (x±SX) surface concentration of pits of all transverse dimensions 
detected on the surfaces of cells of each group of rats administered magnetite 
particles of different diameters and of control rats (Ref).
Figure 8 engulfment of 10 nm magnetite particles by an alveolar macrophage. 
Notes: Transmission electron microscopy, magnification ×140,000. Phagosomes 
are shown with arrows 1. 
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Some inferences from in vivo experiments with metallic nanoparticles
NPs), another now widely recognized major mechanism of 
NP cytotoxicity and, especially, genotoxicity is the genera-
tion of ROS.102 
The toxic impact of particles on lung phagocytes is of a 
special significance not only as an important unfavorable factor 
influencing pulmonary clearance but also as an in vivo assess-
ment of comparative particle cytotoxicity in a broader sense of 
the term. As it was mentioned above, recruitment of new ech-
elons of NLs (beginning from enhanced differentiation of stem 
cells) prevailing over that of macrophages is a mechanism of 
compensation, even if partial, for the breakdown of AMs dam-
aged by cytotoxic particles. It was found that this recruitment 
is controlled by the mass of macrophage breakdown products 
(MBP) and especially by their lipid fraction.96–100 Therefore, 
the more cytotoxic for AMs are particles deposited in the lungs 
(or the higher the dose of MBPs obtained by aseptic freezing-
thawing or ultrasonic destruction of non-activated peritoneal 
macrophages and then instilled intratracheally), the higher is 
a count ratio of NLs to AMs in the BALF. Therefore this ratio 
(NL/AM) can be used as an indirect but highly informative 
comparative in vivo index for the cytotoxic action of any 
low-soluble particle, and it was demonstrated that ranking of 
dusts by this index was well correlated with the ranking of 
their cytotoxicity based on the Trypan blue exclusion test for 
cell viability in vitro. All these earlier revealed facts permitted 
us to use the BALF NL/AM ratio as an in vivo estimate of 
comparative cytotoxicity for NPs as well.
Using this index, we showed that the investigated NPs 
were far more cytotoxic as compared with even the smallest 
MPs of the same metal (as examples, see Table 1 for silver 
NPs versus MPs as well as the values given in the text above 
for copper oxide NPs versus submicron particles). Moreover, 
within the nanoscale range, the smaller a particle, the more 
cytotoxic it was (see Figure 3 for iron oxide particles with 
different dimensions). Given a virtually equal nanoscale size, 
the cytotoxicity of particles can be quite different depending 
on their chemical nature. Thus we found, judging by NL/FM 
ratio, that nano-Ag was far more cytotoxic as compared with 
nano-Au (see the NL/AM column in Table 2) and that nano-
NiO was more cytotoxic as compared with nano-Mn
3
O
4
.10 
Table 2 Number of cells in the bronchoalveolar lavage fluid (BALF) 24 hours after the intratracheal instillation of suspension of gold 
(50 nm) or silver (49 nm) particles to rats at a dose of 0.2 mg per rat (x±se)
Substance 
administered
Number of cells ×106 NL/AM
Total Neutrophil  
leukocytes (NL)
Alveolar  
macrophages (AM)
Nanosilver 4.25±0.77* 2.99±0.71* 1.16±0.14 2.47±0.33*
Nanogold 2.30±0.93• 0.63±0.15*,• 0.94±0.09 0.63±0.13*,•
water (controls) 1.41±0.33 0.13±0.04 0.89±0.18 0.14±0.023
Notes: Statistically significant difference *from control group; •from nanosilver group (P0.05 by Student’s t-test).
Figure 9 Gold nanoparticles uniformly distributed throughout the cytoplasm and 
nucleus of an alveolar macrophage. 
Notes: The two-contour organization of the nucleus membrane is intact throughout. 
There is a mitochondrion visible which is not interacting with nanoparticles but, 
nevertheless, is intact only partly. Transmission electron microscopy, magnification 
×22,000.
Figure 10 An alveolar macrophage. 
Notes: Penetration of silver nanoparticles from aggregates in the cytoplasm into 
mitochondria (arrows). No silver nanoparticles are discovered in the nucleus. 
Transmission electron microscopy, magnification ×28,000.
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There are differences also in ultrastructural damage to the 
macrophage caused by different nanometals. For instance, 
nanosilver was found more prone to damage mitochondrial 
membranes and cristae than nanogold.7 
Different solubility of different nanometals is one of prob-
able explanations of their different cytotoxicity (in particular, 
silver NPs were proved more soluble as compared with 
equidimensional gold ones) but hardly the only one. Based 
on a review of extensive literature, Fröhlich102 believes that, 
commonly for many metals and their oxides, the release of 
free ions is a second important mechanism of NP cytotoxic-
ity (the first one being the generation of ROS as a result of 
various chemical reactions).
When comparing the BALF cell absolute counts and 
quantity of “pits” on the surface of these cells revealed by 
the sc-AFM with the NL/AM ratio values, we can see that the 
more cytotoxic the NPs are (because of either their smaller 
dimensions or their chemical nature, or both) the more active 
the pulmonary phagocytosis response is and the more avidly 
these NPs are engulfed by phagocytes. This phenomenon 
can be easily explained, as MBPs stimulate not only the 
recruitment but also the phagocytic activity of viable mac-
rophages judging by the results of an in vitro test with 1 μm 
polystyrene beadles.103 It stands to reason, however, that such 
compensation for AMs’ breakdown cannot be complete and, 
in the final count, the especially high cytotoxicity of NPs can 
be regarded as their very dangerous characteristic increasing 
along with decrease in their diameter.
The relationship between particle dimensions and their 
toxicity is not so unequivocal on the organs and organism 
levels. For instance, judging by our results,1,3 the subchronic 
toxicity of magnetite NPs was higher as compared with 
that of 1 μm particles, but within the nano-scale range the 
relationship under consideration proved inverse for some 
effects. Such seemingly paradoxical dependence of adverse 
effects of NPs on their diameter is quite characteristic of 
target organs rich in reticuloendothelial system and thus 
capable of actively accumulating NPs from blood – such as 
liver and spleen.
This fact should be attributed to differences in NP toxi-
cokinetics. The latter is controlled, first of all, by their more 
or less easy penetration through biological barriers into the 
bloodstream from sites of their primary deposition to be then 
captured by reticuloendothelial system cells of this or that 
organ. It may be assumed that this mechanism of particle 
translocation has to be more effective for smaller NPs. How-
ever, the smaller the particle, the quicker it dissolves from 
these secondary depots due to its immense specific surface. 
Besides, the smallest NPs are presumably more cytotoxic 
for any cells, resident macrophages included, and so cause 
their destruction (with eventual liberation of NPs back to 
bloodstream) more effectively. The balance between these 
oppositely acting mechanisms of NP retention in different 
tissues depends on many variables. The result can be a greater 
load of an organ with larger NPs than with smaller ones (but, 
at the same time, much greater for both as compared with 
microparticles) as illustrated for magnetite NPs and MPs in 
Figure 11. It is no wonder that some morphometric indices 
for the toxic damage to the liver were more prominent in 
rats exposed to 50 nm particles than to 10 nm particles of 
magnetite, while NPs of both sizes proved more hepatotoxic 
as compared with microparticles (Table 3).
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Figure 11 Mean value (± standard deviation) of iron oxide (magnetite) concentration in the rat tissues of (A) liver and (B) spleen after repeated intraperitoneal injections 
of magnetite particles of different size. 
Note: electron paramagnetic resonance method.
Abbreviaton: NPs, nanoparticles.
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Some inferences from in vivo experiments with metallic nanoparticles
Above any doubt, the systemic toxicity of equidimen-
sional NPs depends on the toxic properties of the metal as 
such and can differ very much between different metals. For 
instance, nanosilver is more toxic than nanogold when tested 
in parallel, and specifically, nanosilver is more genotoxic 
in vivo compared with nanogold judging by the results of 
the random amplified polymorphic DNA test performed on 
cells of different tissues of rats under subchronic intoxication 
(Table 4).7 The fact that these differences in the genotoxicity 
of nanometals compared are less pronounced in the kidneys, 
can, most probably, be explained by the fact that silver NPs, 
which, judging by their considerably higher solubility in a 
model biomedium in vitro as compared with gold NPs,7 release 
substantially higher concentrations of ions into the blood as 
well in vivo, and, therefore, possess higher nephrotoxicity. 
We believe that marked toxic damage of kidney epithelial 
cells can mask the metal’s genotoxic effect. This hypothesis 
found confirmation in an experiment with copper oxide NPs,8 
which are even more soluble in vivo and thus even more 
nephrotoxic compared with silver NPs. In that experiment, 
the kidneys proved to be the only organ in which the DNA 
fragmentation coefficient was not elevated in response to 
subchronic intoxication by copper oxide NPs in comparison 
with controls. Meanwhile, in a parallel group, in which 
the animals were exposed to the same CuO NPs but against 
the background of bioprotectors (see “Is it possible to protect 
the health of people exposed occupationally to metallic NPs in 
the workroom air by enhancing organism’s resistance to their 
adverse action?” section), the morphometric data revealed a 
considerably lower death rate of tubular epithelial cells, while 
it was just against this background that a significant genotoxic 
effect of nano-CuO became quite manifested.
Is it possible to protect the health of 
people exposed occupationally to metallic 
NPs in the workroom air by establishing 
very low but still practicable PeLs?
Although the problem of nanomaterials’ health risk assessment 
and management is discussed widely and has been comprehen-
sively reviewed by many authors,104,105 a general methodology 
of safe exposure standard setting in this field is still lacking, 
and there are but few examples of establishing or recommend-
ing reference exposure levels for specific engineered NPs in 
workroom air. Thus in most cases, in the field of nano-safety 
both risk assessments and risk management scenarios still have 
to be implemented with the qualification that exposure limits 
for individual nano-materials are not available.106 Given this 
serious uncertainty, the precautionary approach is that of choice 
in the worker’s health protection in nanotechnology.107 
Irrespective of whether toxicologists of this or that 
country believe in a no-threshold character of the dose-
effect relationship for any or, at least, for genotoxic and 
carcinogenic harmful substances or stick to the paradigm of 
the existence of thresholds for any harmful effects, there are 
little doubts as to the practical need for, and the possibility 
of establishing presumably safe exposure levels. In a grow-
ing number of countries such levels are set as law enforce-
able standards, in particular, for the workplace air quality. 
Whatever such standards are called (maximal allowable 
concentrations, PELs, reference exposure levels, workplace 
exposure limit, occupational exposure limits, etc), establish-
ing them is justified by assuming, explicitly or by default, 
that the evolutionarily acquired protective mechanisms and 
Table 3 Some morphometric indices for the state of rat’s liver 
after subchronic exposure to iron oxide (magnetite) particles 
(x±se)
Count per 100  
liver cells
Groups of rats
Control Exposed to magnetite particles
10 nm 50 nm 1 μm
Akaryotic hepatocytes 13.1±0.9 37.0±1.6*,•, 44.4±1.3*, 19.6±1.7*
Binucleated hepatocytes 5.1±0.5 2.3±0.3*, 2.0±0.3*, 6.1±0.6
Kupffer cells 27.2±1.6 31.8±2.0• 19.2±3.3 33.2±0.4*
Notes: *A statistically significant difference from the control group; •from the 50 nm 
group; from the 1 μm group (P0.05 by Student’s t-test and by Mann–whitney test).
Table 4 Coefficients of the genomic DNA fragmentation in rats exposed to subchronic administration of silver or gold nanoparticles 
(based on the results of RAPD-test), x±se
Group of rats  
exposed to
Tissues
Liver Bone marrow Spleen Kidney Nucleated cells of 
peripheral blood
water (controls) 0.399±0.001 0.385±0.003 0.379±0.002 0.385±0.003 0.383±0.001
Nanogold 0.392±0.010° 0.412±0.014* 0.397±0.008° 0.422±0.009* 0.403±0.018
Nanosilver 0.461±0.002* 0.455±0.032* 0.462±0.001* 0.423±0.008* 0.413±0.012*
Notes: Statistically significant difference *from the control group; °between the group receiving nanogold and the group receiving nanosilver (P0.05 by Student’s t-test).
Abbreviation: RAPD, random amplified polymorphic DNA.
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the compensation abilities of the organism enable humans 
to exist under some low level of harmful exposure without 
any appreciable impairment of health and any perceptible rise 
over the background risks of stochastic harmful effects.
The experimental results as discussed above permitted us 
to maintain that the concept of quasi-defenselessness of the 
organism against NPs had to be critically re-evaluated. On 
the other hand, however, they provided evidence supporting 
the prevailing presumption that particulates, even ones that 
are relatively innocuous in the micrometer range (like iron 
oxides), may be markedly toxic in the nano-state while within 
the conventional nanometer range the dependence of toxicity 
on particle size proved intricate and non-unique. Therefore 
we believe that: a) establishing permissible or reference 
values for controlling and assessing health risks due to NPs 
exposures is possible in principle; b) such levels should be 
significantly lower as compared with actual exposure limits 
established (or recommended) for chemically identical MPs; 
and c) there are no reliable foundations as yet for differentiat-
ing such standards for particles of different nano-size. 
As to a well-known example of such approach, we may 
refer to the recommended exposure limit (REL) 0.3 mg/m3 
proposed by the US National Institute for Occupational 
Safety and Health (NIOSH) for the ultrafine (including 
engineered nanoscale) TiO
2
 particles that is eight times 
lower than REL 2.4 mg/m3 for the fine TiO
2
.108 It is true that 
the NIOSH maintains that “similarly for other particulate 
materials, if the toxicity varies by particle size (at the same 
mass dose), distinct exposure limits for distinct particle size 
fractions might be a reasonable approach for protecting 
exposed workers”. Nevertheless, one and the same REL is 
proposed for all the TiO
2
 nano-scale fractions while just the 
TiO
2
 commercial nano-powders are being manufactured 
and marketed for a variety of uses in a rather wide range of 
primary particle diameters (for instance, ~10 nm, 10–30, 
or 50 nm). Thus we may say that the NIOSH REL proposal 
is in good accordance with, though established independently 
of, the above postulates (b and c) of ours.
A similar but even more conservative approach to estab-
lishing exposure standards for engineered nanomaterials was 
proposed in 2010 by the Australian Government agency “Safe 
Work Australia”: for nanocrystals, quantum dots, ceramic 
oxides, and metals the suggested benchmark exposure level 
should be 0.066 WEL (workplace exposure limit for bulk 
material), that is by diminishing the latter by a factor of 15. 
In accordance with this regulatory practice, we also 
believe that for workroom air concentrations of metallic NPs, 
PELs at this historical stage can and should be based, even if 
tentatively, on a sufficiently conservative rule of decreasing 
approximately tenfold the exposure limits previously estab-
lished for respective micro-scale industrial aerosols. Acting 
along this line, we propose tentative PELs for NPs of iron oxide 
(0.4 mg/m3), copper oxide (0.05 mg/m3), silver (0.1 mg/m3), 
and gold (0.2 mg/m3). As an example, we will discuss here in 
more detail the case of Fe
3
O
4
 NPs as presented by us.4
To begin with, workroom exposure standards are estab-
lished in different countries for only one of the iron oxides – 
namely Fe
2
O
3
. It may be assumed, however, that there is 
no significant difference in toxicity between different iron 
oxides. For example, the Joint Expert Committee on Food 
Additives gives one and the same acceptable daily intake 
value for Fe
3
O
4 
(the so-called black iron [II, III] oxide) and 
for anhydrous or hydrated Fe
2
O
3 
(respectively, red and yellow 
iron [III] oxides). So, as a starting point for calculating a ten-
tative PEL for nano Fe
3
O
4 
one might assume by inference the 
actual standards for Fe
2
O
3 
dust and/or fumes which are: 
•	 USA Occupational Safety and Health Administration PEL – 
time-weighted average (TWA) 10 mg/m3 (as Fe);
•	 USA NIOSH REL – TWA 5 mg/m3 (as Fe);
•	 Canadian Occupational Exposure Limit – TWA 5 mg/m3 
for respirable dust (in Alberta) or 10 mg/m3 for total dust 
(in British Columbia);
•	 Russian Maximum Allowable Concentration (MAC) – 
work shift average 6 mg/m3. 
Note that the Russian MAC established for whole Fe
2
O
3 
substance is equivalent to ~2 mg/m3 if re-calculated for Fe, 
and thus it is actually the most conservative of all these stan-
dards. Taking into consideration the precautionary principle, 
we proposed to start just from this MAC and, moreover, to 
diminish it not eight but 15 times (in accordance with the 
above-mentioned Australian suggestion as the most conser-
vative, too). Thus we obtained the value 6×0.066≈0.4 mg/m3 
(as TWA). This value is close enough to the above-mentioned 
NIOSH REL for ultrafine TiO
2 
(0.3 mg/m3). 
There is no doubt that a more sophisticated study of 
the same nanomaterials’ adverse effects (their possible 
Table 5 Succinate dehydrogenase activity (number of formasan 
granules per 50 blood lymphocytes) in rats exposed to subchronic 
administration of nanosilver particles with and without protection 
by a bio-protective complex (BPC) (x±se)
Groups of rats given
Nanosilver (NS) NS +	BPC BPC Controls
679.9±12.4*,• 827.8±22.1 834.1±11.2 805.33±12.6
Notes: Statistically significant difference *from the controls; •from the NS + BPC 
group (P0.05 by Student’s t-test).
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carcinogenicity included) and of dose-response relationships, 
as well as further discussion of a general methodology for 
substantiating reference exposure levels for nanomaterials 
will be necessary to make such safety standards more reliable. 
Nevertheless, we believe that, for the time being, it is wiser to 
use the standards obtained with the above-discussed approach 
(tentative but still not spun out of thin air and obligatorily 
based on results of actual comparative toxicological experi-
ments) than to be passively waiting for better ones. 
Is it possible to protect the health 
of people exposed occupationally 
to metallic NPs in the workroom air by 
enhancing organisms’ resistance to their 
adverse action?
However low the levels of exposure to NPs were established 
as permissible, the especially high toxicity of this class of 
occupational hazards makes it worthwhile to search for possi-
bilities to render exposed people less sensitive to their effects 
with the help of a combination of specific and unspecific 
agents which are innocuous themselves in preventively 
effective doses. The general concept of such “biological 
prophylaxis” of different occupational and environmental 
intoxications, its theoretical premises and general principles 
along with numerous examples of their realization have been 
published by us over several decades repeatedly, including, 
in review articles.109,110 Now we began to use this experience 
for trying to protect the organism against the impacts of 
nanometals. 
In particular, our experiments have demonstrated that 
both systemic toxicity and in vivo genotoxicity of silver7 and 
of copper oxide8 NPs were markedly attenuated against the 
background of oral administration of multi-component BPC. 
These BPCs comprised pectin, multivitamin–multimineral 
preparations, some amino acids, and omega-3 polyunsatu-
rated fatty acid (for the detailed BPCs’ composition and doses 
see the above references).7,8 In both cases the protective action 
was demonstrated in respect to many adverse effects of sub-
chronic toxicity. Some illustrations are given in Tables 5–7, 
and in Figures 12 and 13.
We found as well10 that in rats that were being given glu-
tamate, glycine, acetyl cysteine, iodide, and a Se-containing 
multivitamin preparation orally during 4 weeks before a 
single IT instillation of NiO+Mn
3
O
4
 NPs (0.25 mg each), 
the latter evoked a significantly lower NL recruitment with 
lower NL/AM ratio than in rats so exposed without any 
pretreatment. 
Conclusion
The investigated metallic NPs are much more noxious on 
both cellular and systemic levels as compared with their fine 
micrometric or even submicron counterparts. However, within 
the conventional nanometer range the dependence of systemic 
toxicity on particle size is intricate and non-unique due to 
complex and often contra-directional relationships between 
the intrinsic biological aggressiveness of specific NPs (in 
particular, their cytotoxicity), on the one hand, and complex 
mechanisms that control their biokinetics, on the other.
Our data testify to a high activity of at least one of 
the key physiological defense mechanisms (pulmonary 
Table 6 Morphometric indices for tubular epithelium damage in 
kidneys of rats after repeat intraperitoneal injections of copper 
oxide nano-suspensions and/or oral administration of the bio-
protective complex (BPC) (x±se)
Groups of rats given Brush border loss  
(% lengthwise)
Epithelial 
desquamation 
(% lengthwise)
water (control) 5.39±0.42 0.33±0.13
Nano copper oxide 8.36±0.76* 1.16±0.38*
Nano copper oxide + BPC 5.98±0.46 0.98±0.35
BPC 6.03±0.57 0.73±0.21
Notes: Statistically significant difference *from the control group; from the group 
given nano copper oxide (without the BPC); P0.05 (P0.05 by Student’s t-test).
Table 7 Coefficients of the genomic DNA fragmentation in rats exposed to subchronic administration of nanosilver particles with and 
without protection by a bio-protective complex (BPC) (based on the results of RAPD-test), x±se
Group of rats  
exposed to
Tissues
Liver Bone marrow Spleen Kidney Nucleated cells of 
peripheral blood
water (controls) 0.399±0.001 0.385±0.003 0.379±0.002 0.385±0.003 0.383±0.001
Nanosilver (NS) 0.461±0.002* 0.455±0.032* 0.462±0.001* 0.423±0.008* 0.413±0.012*
NS + BPC 0.408±0.011+ 0.373±0.003*,+ 0.419±0.003*,+ 0.407±0.006*,+ 0.390±0.007
Notes: Statistically significant difference *from the control group; +between the group given NS together with BPC and the group given NS only (P0.05 by Student’s t-test).
Abbreviation: RAPD, random amplified polymorphic DNA.
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Figure 13 Number of cells without a nucleolus per 100 Golgi cells in nucleus 
caudatus of rats exposed (A) to water (control); (B) to water suspension of copper 
oxide nanoparticles; (C) to the same against the background of BPC administrations; 
(D) to the BPC only (average values with 95% confidence interval). 
Notes: Differences are statistically significant between (B) and (A); (C) and (B) 
(P0.05 by Student’s t-test).
Abbreviation: BPC, bio-protective complexes.
phagocytosis of deposited particles) against NPs deposited 
in airways. This fact suggests that safe low levels of expo-
sure to airborne NPs are possible in principle. For the time 
being, however, there seems to be no reliable foundations 
for establishing different PELs for particles of different sizes 
within the established nanometric range. For workroom air 
concentrations of metallic NPs, PELs can be proposed at this 
stage, even if tentatively, based on a sufficiently conserva-
tive approach of decreasing by approximately an order of 
magnitude the exposure limits established for respective 
micro-scale industrial aerosols. Acting along this line, we 
propose tentative PELs for NPs of iron oxide (0.4 mg/m3), 
copper oxide (0.05 mg/m3), silver (0.1 mg/m3), and gold 
(0.2 mg/m3). However, to substantiate more reliable stan-
dards of presumably safe occupational exposures to metallic 
NPs, a wide international program of long-term inhalation 
experiments with such low-level concentrations and with a 
broad spectrum of toxicity, genotoxicity, and carcinogenicity 
indices has to be designed and implemented.
It has been shown that against the background of ade-
quately composed combinations of some bioactive agents 
used in innocuous doses the toxicity and even genotoxicity 
of metallic NPs could be markedly attenuated. Therefore 
we believe that, along with decreasing exposures to NPs, 
enhancing organisms’ resistance to their adverse action with 
the help of such bioprotectors can prove an efficient auxil-
iary tool of health risk management in related occupations 
and strongly recommend to further develop this vector of 
nanotoxicological research. 
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